Ramucirumab: A vascular endothelial growth factor receptor-2 inhibitor with activity in several malignancies
Author:
Affiliation:
1. University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO
Publisher
Oxford University Press (OUP)
Subject
Health Policy,Pharmacology
Link
http://academic.oup.com/ajhp/article-pdf/73/13/957/28335588/ajhp0957.pdf
Reference24 articles.
1. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis;Hicklin;J Clin Oncol,2005
2. Phase I pharmacologic and biologic study of ramucirumab (IMC-1121B), a fully human immunoglobulin G1 monoclonal antibody targeting the vascular endothelial growth factor receptor-2;Spratlin;J Clin Oncol,2010
3. Tumor angiogenesis;Kerbel;N Engl J Med,2008
4. Angiogenesis and the tumor microenvironment: vascular endothelial growth factor and beyond;Mittal;Semin Oncol,2014
5. Hallmarks of cancer: the next generation;Hanahan;Cell,2011
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Recent development of VEGFR small molecule inhibitors as anticancer agents: A patent review (2021–2023);Bioorganic Chemistry;2024-05
2. Assessing patient risk, benefit, and outcomes in drug development: A decade of ramucirumab clinical trials;Cancer Medicine;2024-05
3. Management of Acute Coronary Syndrome in Cancer Patients: It’s High Time We Dealt with It;Journal of Clinical Medicine;2022-03-24
4. Angiogenesis as a potential treatment strategy for rheumatoid arthritis;European Journal of Pharmacology;2021-11
5. Enhancement of tumour penetration by nanomedicines through strategies based on transport processes and barriers;Journal of Controlled Release;2020-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3